U.S. FDA gives early approval to Sarepta's DMD gene therapy

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009. REUTERS/Jason Reed/File Photo

(Reuters) – The U.S. Food and Drug Administration on Thursday granted an early approval to Sarepta Therapeutics Inc’s gene therapy for Duchenne muscular dystrophy (DMD).

DMD is a rare, genetic disorder that hampers muscle movement mainly in men, affecting one in every 3,500 to 5,000 males.

It can cause life-threatening damage to the heart, and over time, death, often at a young age.

Reporting by Dania Nadeem in Bengaluru; Editing by Sriraj Kalluvila

Our Standards:The Thomson Reuters Trust Principles.

source: reuters.com

🕐 Top News in the Last Hour By Importance Score

#	Title	📊 i-Score
1	Israel's army says it will fire air force reservists who condemned war in Gaza	🔴 75 / 100
2	Russia economy meltdown as nation 'bleeding cash' and China 'shies away' from oil exports	🔴 72 / 100
3	‘As an environmental scientist, I’m horrified’: Should supersonic passenger travel be making a comeback?	🔴 72 / 100
4	Gripping story of Trump's 'savior' Scott Bessent shoved aside MAGA loyalists to save the world from economic oblivion	🔴 72 / 100
5	ALEX BRUMMER: Labour look all at sea due to Cabinet's lack of commercial experience and wisdom	🔴 72 / 100
6	Mysterious triangular tower at Area 51 is discovered on Google Maps – as baffled viewers suggest it could be 'alien technology'	🔴 65 / 100
7	Jonathan McDowell on Retiring From Harvard and Leaving the U.S.	🔴 62 / 100
8	A practical guide to collecting Japan's eki stamps	🔵 60 / 100
9	Operation Lovecraft New Update April 10th 2025	🔵 45 / 100
10	Three rowers banned from 2025 boat race and one race cancelled as chaos erupts	🔵 40 / 100

View More Top News ➡️